Patent details

Basic Information

Publication number:

EP2548582

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP111596649

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Antitumoral bioconjugates of hyaluronic acid or its derivatives obtained by indirect chemical conjugation

French Title of Invention:

Bio-conjugués antitumoraux d'acide hyaluronique ou ses dérivés obtenus par une conjugaison chimique indirecte

German Title of Invention:

Mittels indirekter chemischer Konjugation erhaltene Antitumor-Biokonjugate von Hyaluronsäure oder Derivaten davon

SPC Number:

Dates

Filing date:

02/08/2006

Grant date:

19/09/2018

EP Publication Date:

23/01/2013

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

19/09/2018

EP B1 Publication Date:

19/09/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

02/08/2019

Expiration date:

02/08/2026

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

12/09/2018

 

 

Name:

Fidia Farmaceutici S.p.A.

Address:

Via Ponte della Fabbrica 3/A, 35031 Abano Terme (PD), Italy (IT)

Inventor

1

Name:

Renier, Davide

Address:

Italy (IT)

2

Name:

Bettella, Fabio

Address:

Italy (IT)

Priority

Priority Number:

PD20050242

Priority Date:

03/08/2005

Priority Country:

Italy (IT)

Classification

IPC classification:

A61P 35/00; A61K 47/61;

Publication

European Patent Bulletin

Issue number:

201838

Publication date:

19/09/2018

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages